Literature DB >> 7957510

Antidepressants in suicide: differences in fatality and drug utilisation.

J Malmvik1, C G Löwenhielm, A Melander.   

Abstract

All forensic autopsy cases in southern Sweden in 1986-89 in which antidepressant drugs were found in the blood were assessed and the findings related to the sales of antidepressants as expressed as defined daily doses per 1,000 inhabitants per day. There was a total of 272 antidepressant-positive cases, which were divided in three groups: 1. suicide or possible suicide caused by antidepressant drugs, 2. suicide or possible suicide caused by other means (including other drugs and other toxic agents), and 3. other deaths. Amitriptyline was the agent most commonly involved in suicide or possible suicide caused by antidepressants, and it was also the most commonly sold antidepressant. When corrected for sales, trimipramine was most frequently involved as the causal agent. Conversely, despite frequent sales, lofepramine appeared only rarely to be involved. This may be related to lower toxicity of lofepramine, reduced lofepramine absorption at overdose and/or to differences in the administration of various antidepressant drugs to patients with differing degrees of risk of suicide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957510     DOI: 10.1007/BF00194393

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology.

Authors:  A Wessling; G Boëthius
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  On the differences in psychotropic drug use between the three major urban areas in Sweden.

Authors:  A Wessling; U Bergman; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Fatal toxicity of antidepressant drugs in overdose.

Authors:  S Cassidy; J Henry
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

4.  Chemistry and pharmacology of a new potential antidepressant. (N-methyl-N-[4-chlorobenzyl-methyl-3-(10,11-dihydro-5H-dibenz(b,f) azepin-5-yl)]-propylamine hydrochloride). (Leo 640, lopraminehydrochloride).

Authors:  E Eriksoo; O Rohte
Journal:  Arzneimittelforschung       Date:  1970-10

5.  Are there safer hypnotics than barbiturates?

Authors:  B M Barraclough
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

6.  A possible index of fatal drug toxicity in humans.

Authors:  L A King; A C Moffat
Journal:  Med Sci Law       Date:  1983-07       Impact factor: 1.266

7.  A fatal toxicity index for antidepressant poisoning.

Authors:  J A Henry
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

8.  Cardiovascular effects of single doses of the antidepressants amitriptyline and lofepramine in healthy subjects.

Authors:  H Stern; J Konetschny; L Herrmann; U Säwe; G G Belz
Journal:  Pharmacopsychiatry       Date:  1985-07       Impact factor: 5.788

Review 9.  Suicide and antidepressant overdosage in general practice.

Authors:  G Beaumont
Journal:  Br J Psychiatry Suppl       Date:  1989-10

Review 10.  A comparison of the pharmacological properties of the novel tricyclic antidepressant lofepramine with its major metabolite, desipramine: a review.

Authors:  B E Leonard
Journal:  Int Clin Psychopharmacol       Date:  1987-10       Impact factor: 1.659

View more
  3 in total

1.  Patterns of toxicity and factors influencing severity in acute adult trimipramine poisoning.

Authors:  Karen Gutscher; Christine Rauber-Lüthy; Marina Haller; Michèle Braun; Hugo Kupferschmidt; Gerd A Kullak-Ublick; Alessandro Ceschi
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

2.  EJCP and clinical toxicology: the first 40 years.

Authors:  D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  2007-11-16       Impact factor: 2.953

Review 3.  Epidemiology and relative toxicity of antidepressant drugs in overdose.

Authors:  J A Henry
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.